Iovance BiotherapeuticsIOVA
那斯達克 · USD
8.68
-0.02
(-0.23%)
盤中 09/09 11:35 (UTC+8)
09/09 11:35 (UTC+8)
Iovance BiotherapeuticsIOVA
8.68
-0.02
(-0.23%)
財務數據
損益表
- 0.01
- 0.31
- 0.59
- 0.74
- 0.49
- 0.60
- 0.67
- 0.87
- 0.71
- 0.99
- 48.34
- 4250.49
- 88.24
- 25.85
- -33.07
- 21.55
- 12.52
- 28.64
- -17.68
- 39.04
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 99,313 | 71,430 | 86,771 | 67,455 | 59,952 | 49,324 | 73,694 | 58,555 | 31,106 | 715 |
營業成本 | 43,595 | 42,498 | 43,111 | 38,478 | 63,690 | 49,741 | 68,536 | 39,823 | 31,368 | 7,261 |
營業毛利 | 55,718 | 28,932 | 43,660 | 28,977 | -3,738 | -417 | 5,158 | 18,732 | -262 | -6,546 |
營業費用 | 107,623 | 109,975 | 117,120 | 123,878 | 110,036 | 120,804 | 91,734 | - | - | 111,176 |
研發費用 | 58,851 | 62,487 | 71,203 | 75,172 | 80,277 | 76,879 | 77,115 | 68,245 | 62,084 | 79,783 |
推銷及管理費用 | 39,272 | 38,949 | 36,400 | 34,556 | 37,824 | 43,925 | 43,069 | 39,553 | 39,568 | 31,393 |
非經常性項目費用 | - | - | - | 5,143 | - | - | - | - | - | - |
其他營業費用 | 9,500 | 8,539 | 9,517 | 9,007 | -8,065 | - | -28,450 | - | - | - |
營業利益 | -51,905 | -81,043 | -73,460 | -94,901 | -113,774 | -121,221 | -86,576 | -89,066 | -101,914 | -117,722 |
其他收入及費用 | 3,217 | 1,333 | 1,740 | 1,243 | 4,104 | 3,220 | 9,575 | 4,005 | 3,355 | 3,338 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -48,688 | -79,710 | -71,720 | -93,658 | -109,670 | -118,001 | -77,001 | -85,061 | -98,559 | -114,384 |
所得稅 | -1,373 | -665 | 184 | -2,405 | 1,988 | -1,838 | 1,558 | -1,520 | -1,458 | -1,408 |
稅後純益 | -47,315 | -79,045 | -71,904 | -91,253 | -111,658 | -116,163 | -78,559 | -83,541 | -97,101 | -112,976 |
基本每股稅後盈餘(元) | -0.11 | -0.19 | -0.18 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 |
稀釋每股稅後盈餘(元) | -0.10 | -0.19 | -0.15 | -0.25 | -0.33 | -0.36 | -0.25 | -0.27 | -0.34 | -0.42 |
基本平均股數(千股) | 450189.00 | 418511.00 | 406966.00 | 364037.00 | 334511.00 | 322868.00 | 304890.00 | 303269.00 | 284817.00 | 266220.00 |
稀釋平均股數(千股) | 450189.00 | 418511.00 | 406966.00 | 364037.00 | 334511.00 | 322868.00 | 304890.00 | 303269.00 | 284817.00 | 266220.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.19 | -0.18 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 |
還原稀釋每股稅後盈餘(元) | -0.10 | -0.19 | -0.15 | -0.25 | -0.33 | -0.36 | -0.25 | -0.27 | -0.34 | -0.42 |
還原基本平均股數(千股) | 450,189 | 418,511 | 406,966 | 364,037 | 334,511 | 322,868 | 304,890 | 303,269 | 284,817 | 266,220 |
還原稀釋平均股數(千股) | 450,189 | 418,511 | 406,966 | 364,037 | 334,511 | 322,868 | 304,890 | 303,269 | 284,817 | 266,220 |
EBITDA(千元) | -39,699 | -70,415 | -60,418 | -83,851 | -99,605 | -109,082 | -67,074 | -76,568 | -90,194 | -106,812 |